Identix Experiencing Growing Momentum in Healthcare Market for Biometric Authentication Systems & Solutions

Identix Incorporated (Nasdaq:IDNX) said today that it is seeinggrowing traction for the Company's biometric authentication technologyin the healthcare market. Identix is partnered with Sentillion, Inc.,a leading provider of single sign-on solutions for healthcare, to takebiometric single sign-on solutions into the healthcare industry.Together, Identix and Sentillion have delivered their combinedbiometric single sign-on solutions to more than 21 healthcareinstitutions across North America.

Driven by the growing need for heightened security and theincreasingly important requirement for better identification prior togranting access to PCs, company applications and healthcareinstitution and patient information, Identix perceives that leadinghealthcare companies may be increasing adoption of biometricauthentication solutions to safeguard sensitive information. Duringits fiscal 2006 first quarter ending September 30, 2005, Identixreceived purchase orders for Healthcare deployments for itsBioLogon(R) authentication software and from channel partners thatintegrate or embed Identix' enabling BioEngine(R) authenticationtechnologies and accompanying single finger readers representing morethan 35,000 seat licenses. The total value of these purchase orders isapproximately $1.4 million. Identix said it expects to recognizeapproximately half of this revenue in its fiscal 2006 first quarter,with the remainder expected to be recognized in its fiscal 2006 secondquarter ending December 31, 2005.

"We believe the validation and adoption of biometric technology bygovernments throughout the world is beginning to spill over into theenterprise and commercial markets," said Identix President & CEO Dr.Joseph J. Atick. "This is an expected, yet important development; onewhich we believe may mark the beginning of commercial businessbeginning to provide meaningful revenue streams for the biometricsindustry.

"We believe the emergence of meaningful revenue streams in thecommercial space, such as these recent healthcare orders, is anexcellent complement to the solid growth we expect to continue to seein the federal, state & local and international government markets foridentification systems and solutions," Atick continued, "Identix hasinvested hundreds of man years in developing key enabling componentsfor biometric authentication. We believe Identix continues to beuniquely positioned to capitalize on this development in thecommercial space, as our multi-biometric offerings include one-to-oneand one-to-many authentication technology that can be an excellent fitwith the growing need to protect access to data via biometricauthentication. Additionally, because we are not providing anend-to-end solution for these markets, our core finger and facealgorithms and application technology is a natural choice for channelowners such as Sentillion, as well as OEMs and other channel ownersand other solutions companies that are looking to add biometrictechnologies authentication to their offerings. Sentillion has done anexcellent job providing the healthcare industry with a multitude ofrobust, highly scalable and secure single sign-on solutions and welook forward to continuing to work closely with them to expand thebreadth of both companies' offerings."

About BioLogon

Providing fingerprint and password support and designed tointegrate seamlessly into a network's OS for central administration,configuration and maintenance of user account and security policies,BioLogon offers complete multi-factor authentication solution.BioLogon accepts multiple user account login methods, includingbiometrics and PIN combinations, enabling increased security, loweradministrative costs, and added convenience.

About Sentillion

Sentillion provides identity and access management solutions tothe healthcare industry. Sentillion's Vergence(R) product suiteenables healthcare organizations to know who their users are, helpthem be productive, guard their systems and protect their patients.The Vergence product suite includes user provisioning, strongauthentication, single sign-on, clinical context management andprivacy management. Sentillion was named the leading vendor forhealthcare single sign-on for three consecutive years by IDC Researchand was the recipient of the Frost & Sullivan 2004 Customer ValueEnhancement Award in Healthcare. Sentillion is a privately heldcompany headquartered in Andover, Mass. For more information, visitSentillion at www.sentillion.com.

Identix, BioLogon and BioEngine are trademarks or registeredtrademarks of Identix Incorporated in the United States and othercountries.

About Identix Incorporated

Identix Incorporated (Nasdaq:IDNX) is the world's leadingmulti-biometric technology company. Identix provides fingerprint,facial and skin biometric technologies, as well as systems, andcritical system components that empower the identification ofindividuals in large-scale ID and ID management programs. TheCompany's offerings include live scan systems and services forbiometric data capture, mobile systems for on-the-spot ID, and backendstandards-based modules and software components for biometric matchingand data mining. Identix products are used to conduct backgroundchecks, speed travel and commerce via secure identification documents,prevent identity fraud in large-scale government and civil IDprograms, and control access to secure areas and networks. With aglobal network of partners, such as leading system integrators,defense prime contractors and OEMs, Identix serves a broad range ofmarkets including government, law enforcement, gaming, finance,travel, transportation, corporate enterprise and healthcare.

More information on Identix can be accessed via the Company website at http://www.identix.com.

Statements in this press release and that relate to future plans,events or performance are forward-looking statements reflectingmanagement's current expectations, assumptions and estimates of futureperformance and economic conditions. All forward-looking statementsare made in reliance on the safe harbor provisions of the SecuritiesAct of 1933 and the Securities Exchange Act of 1934. Identix cautionsinvestors that forward-looking statements involve risks anduncertainties that may cause actual results to differ materially fromthose expressed or implied in such statements. Risks and uncertaintiesinclude, without limitation, those related to: the availability offunding from government and other customers; the readiness ofcustomers to accept delivery and integration of software and hardwarecomponents on a timely basis; the ability of the Company to achievetargeted levels of software and hardware revenue mixes; increasinglevels of competition; and other risks identified in the Company's SECfilings. The Company disclaims any intention or obligation to updateor revise any forward-looking statements, whether as a result of newinformation, future events, or otherwise.